Yet, in many countries the devices being used to deliver GLP-1s are the same for both the weight loss and T2D populations and, in many cases, were originally designed for delivering insulin, such as Novo Nordisks FlexTouch pen (Wegovy, semaglutide) or Eli Lillys KwikPen (Mounjaro, tirzepatide) outside the US
These compounders must register with the FDA, undergo state pharmacy board inspections, maintain detailed patient records, and follow strict sterility and quality protocols
Inadequate protein intake, reduced physical activity, and dehydration may also contribute
Hesp AC, Schaub JA, Prasad PV et al (2020) The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors
Can I vortex the vial to speed up dissolution